Journal of Critical Care
Volume 21, Issue 2 , Pages 117-124 , June 2006

Economic evaluation in critical care medicine

  • Heather L. Cox, MD

      Affiliations

    • Department of Surgery, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada T2L 2K8
    • ,
  • Kevin B. Laupland, MD, MSc, FRCPC

      Affiliations

    • Department of Critical Care Medicine, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada T2L 2K8
    • Department of Medicine, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada T2L 2K8
    • Department of Community Health Sciences, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada T2L 2K8
    • Corresponding Author InformationCorresponding author. University of Calgary, Calgary, Alberta, Canada T2L 2K8. Tel.: +1 403 770 3208; fax: +1 403 770 3347.
    • ,
  • Braden J. Manns, MD, MSc, FRCPC

      Affiliations

    • Department of Medicine, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada T2L 2K8
    • Department of Community Health Sciences, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada T2L 2K8

References 

  1. Pines JM, Fager SS, Milzman DP. A review of costing methodologies in critical care studies. J Crit Care. 2002;17:181–186
  2. Beauregard CL, Friedman WA. Routine use of postoperative ICU care for elective craniotomy: a cost-benefit analysis. Surg Neurol. 2003;60:483–489[discussion 489]
  3. Cannon MA, Beattie C, Speroff T, et al. The economic benefit of organizational restructuring of the cardiothoracic intensive care unit. J Cardiothorac Vasc Anesth. 2003;17:565–570
  4. Chelluri L, Mendelsohn AB, Belle SH, et al. Hospital costs in patients receiving prolonged mechanical ventilation: does age have an impact?. Crit Care Med. 2003;31:1746–1751
  5. Lee H, Doig CJ, Ghali WA, et al. Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med. 2004;32:981–985
  6. Heyland DK, Kernerman P, Gafni A, et al. Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit?. Crit Care Med. 1996;24:1591–1598
  7. Gyldmark M. A review of cost studies of intensive care units: problems with the cost concept. Crit Care Med. 1995;23:964–972
  8. Neumann PJ, Stone PW, Chapman RH, et al. The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med. 2000;132:964–972
  9. Delaney A, Bagshaw SM, Ferland A, et al. A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care. 2005;9:R575–R582
  10. Drummond M, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997;
  11. Manns B, Doig CJ, Lee H, et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med. 2003;31:449–455
  12. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709
  13. Abad F, Calbo F, Zapater P, et al. Comparative pharmacoeconomic study of vancomycin and teicoplanin in intensive care patients. Int J Antimicrob Agents. 2000;15:65–71
  14. Grassi C, Casali L, Curti E, et al. Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). J Chemother. 2002;14:597–608
  15. Donaldson CaS. Economic evaluations. Oxford: Oxford University Press; 2000;
  16. Olsen J, Donaldson C. Helicopters, hearts and hips: using willingness to pay to set priorities for public sector health care programmes. Soc Sci Med. 1998;46:1–12
  17. Shorr AF. An update on cost-effectiveness analysis in critical care. Curr Opin Crit Care. 2002;8:337–343
  18. Angus DC, Linde-Zwirble WT, Clermont G, et al. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med. 2003;31:1–11
  19. Manns BJ, Taub KJ, Donaldson C. Economic evaluation and end-stage renal disease: from basics to bedside. Am J Kidney Dis. 2000;36:12–28
  20. Salomon JA, Murray CJ. A multi-method approach to measuring health-state valuations. Health Econ. 2004;13:281–290
  21. Spencer A. The implications of linking questions within the SG and TTO methods. Health Econ. 2004;13:807–818
  22. Group E. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208
  23. Manns BJ, Lee H, Doig CJ, et al. An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med. 2002;347:993–1000
  24. O'Brien BJ, Willan A, Blackhouse G, et al. Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?. Am Heart J. 2000;139:423–429
  25. Cohen M, Demers C, Gurfinkel EP, et al. Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in Non–Q-wave Coronary Events. Am J Cardiol. 1998;82:19L–24L
  26. O'Brien B. Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?. Med Care. 1996;34:DS99–DS108
  27. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102–109
  28. Schulman K, Burke J, Drummond M, et al. Resource costing for multinational neurologic clinical trials: methods and results. Health Econ. 1998;7:629–638
  29. Cohen DJ, Breall JA, Ho KK, et al. Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol. 1993;22:1052–1059
  30. Taira DA, Seto TB, Siegrist R, et al. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J. 2003;145:452–458
  31. Assessment CCOfHT: Guidelines for economic evaluation of pharmaceuticals. Ottawa, 1997.
  32. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313:275–283
  33. Gold M, Siegel JE, Russell LB, Weinstein M. Cost effectiveness in health and medicine. New York: Oxford University Press; 1996;
  34. MacLaren R, Sullivan PW. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. Value Health. 2005;8:105–116
  35. Mason J, Drummond M, Torrance G. Some guidelines on the use of cost effectiveness league tables. BMJ. 1993;306:570–572
  36. Brouwer WB, Niessen LW, Postma MJ, et al. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ. 2005;331:446–448
  37. Polinder S, Meerding WJ, van Exel J, et al. Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy. Pharmacoeconomics. 2005;23:791–802
  38. Soto J. Health economic evaluations using decision analytic modeling. Principles and practices—utilization of a checklist to their development and appraisal. Int J Technol Assess Health Care. 2002;18:94–111
  39. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 1999;341:785–792
  40. Marra CA, Frighetto L, Goodfellow AF, et al. Willingness to pay to assess patient preferences for therapy in a Canadian setting. BMC Health Serv Res. 2005;5:43
  41. O'Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preference?. Med Decis Making. 1994;14:289–297
  42. Olsen JA, Smith RD. Theory versus practice: a review of “willingness-to-pay” in health and health care. Health Econ. 2001;10:39–52
  43. Smith RD. The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigation. Health Econ. 2001;10:487–497

PII: S0883-9441(06)00029-3

doi: 10.1016/j.jcrc.2006.02.003

Journal of Critical Care
Volume 21, Issue 2 , Pages 117-124 , June 2006

Article Tools

* Image Usage & Resolution